Baillie Gifford & CO Illumina, Inc. Transaction History
Baillie Gifford & CO
- $128 Billion
- Q2 2025
A detailed history of Baillie Gifford & CO transactions in Illumina, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 1,741,153 shares of ILMN stock, worth $171 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
1,741,153
Previous 3,010,792
42.17%
Holding current value
$171 Million
Previous $239 Million
30.46%
% of portfolio
0.13%
Previous 0.22%
Shares
33 transactions
Others Institutions Holding ILMN
# of Institutions
870Shares Held
153MCall Options Held
6.88MPut Options Held
1.1M-
Black Rock Inc. New York, NY18.1MShares$1.78 Billion0.04% of portfolio
-
Capital World Investors Los Angeles, CA16.6MShares$1.63 Billion0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$1.49 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.62MShares$552 Million0.02% of portfolio
-
Sessa Capital Im, L.P. New York, NY4.72MShares$464 Million13.63% of portfolio
About ILLUMINA, INC.
- Ticker ILMN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 157,300,000
- Market Cap $15.5B
- Description
- Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....